National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 clinical management
National Institute for the Infectious Diseases "L. Spallanzani", IRCCS. Recommendations for COVID-19 clinical management
复制标题
DOI：
10.4081/idr.2020.8543
复制
发表时间：
2020-01-01
影响因子：
3.2
通讯作者：
Antinori, Andrea
中科院分区：
文献类型：
--
作者：
Nicastri, Emanuele;Petrosillo, Nicola;Antinori, Andrea
2020 年 1 月 9 日，世界卫生组织 (WHO) 宣布中国卫生部门发现了一种新型冠状病毒，进一步归类为 SARS-CoV-2，可导致从无症状病例到严重呼吸道感染的疾病 (COVID-19)。 2020 年 3 月 9 日，世界卫生组织宣布 COVID-19 为全球大流行病。意大利是继中国之后受新冠肺炎 (COVID-19) 感染影响第二严重的国家。意大利罗马 IRCCS“L. Spallanzani”国家传染病研究所是意大利第一家收治和管理受 COVID-19 影响的患者的医院。在此，我们基于非常有限的临床证据提出了对 COVID-19 患者的管理建议；它们应被视为专家意见，可以根据新产生的文献数据进行修改。
On January 9 2020, the World Health Organization (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a disease (COVID-19) ranging from asymptomatic cases to severe respiratory involvement. On March 9 2020, WHO declared COVID-19 a global pandemic. Italy is the second most affected country by COVID-19 infection after China. The "L. Spallanzani" National Institute for the Infectious Diseases, IRCCS, Rome, Italy, has been the first Italian hospital to admit and manage patients affected by COVID-19. Hereby, we show our recommendations for the management of COVID-19 patients, based on very limited clinical evidences; they should be considered as expert opinions, which may be modified according to newly produced literature data.